Pfizer benefits from sales of COVID-19 treatments

Pfizer reported higher-than-expected profits due to strong sales of COVID treatment Paxlovid, a major victory for chief executive Albert Bourla as he takes on activist investor Starboard.

Teile diesen Beitrag: